A bipartisan group of lawmakers is introducing legislation on Monday to toughen U.S. trade enforcement laws and address the ...
In a recent press release touting the president’s removal of “illegal immigrant killers and drug dealers,” Trump made ...
Michael Sayih and Max Fink have finished the Chicago, New York, Boston, London and Berlin marathons together. They hope to ...
AIM ImmunoTech (AIM) announced that the Company’s Board of Directors has, by unanimous vote, appointed David Chemerow as an Independent Director ...
The external shape of the AIM-260 seems to be the same we already saw in 2022 when the U.S. Air Force announced the F-22 ...
The motion seeks to suppress all evidence obtained through these federal searches or grant a hearing to examine the ...
President Trump’s Middle East envoy Steve Witkoff, who previously helped seal the first phase of the deal, is heading to the ...
AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the first new subject has been dosed in Phase 2 of the Phase 1b/2 clinical trial involving AIM’s Ampligen ...